Alopecia areata is an immune response, meaning it’s caused by how your body defends itself against viruses, bacteria, and other foreign substances. Immune responses can be inflammatory, and some of ...

Alopecia areata incidence increased globally from 1990 to 2021, with ASIR slightly declining, indicating complex socioeconomic and health care factors at play. The disease affects 2% of the global ...

The alopecia areata market is expected to grow significantly as awareness of the condition increases, potentially expanding further in the coming ...

Please provide your email address to receive an email when new articles are posted on . Alopecia areata was classified as early-onset, severe or prolonged. Each additional atopic comorbidity raised ...

When Keira was diagnosed with alopecia areata at just 2 years old, her mother, Leslie, felt lost and unsure where to turn for support. "It was so isolating and lonely," said Leslie. "I felt desperate ...

Alopecia areata is an autoimmune disease that causes hair loss. Although there are several treatment options available for alopecia areata, not all of them are effective, which can be frustrating and ...

TORONTO, Jan. 14, 2026 /CNW/ - Eli Lilly Canada Inc. ("Lilly") announced today that Ontario leads the way as the first province to add Olumiant ® for severe alopecia areata to its public drug ...

The alopecia areata market is expected to grow significantly as awareness of the condition increases, potentially expanding further in the coming years, supported by rising prevalence. Additionally ...